Retraction: Mir-124 Attenuates STAT3-Mediated TH17 Differentiation in Colitis-Driven Colon Cancer
- 1Department of Endoscopy, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China
- 2Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangdong Provincial Key Laboratory of Gastroenterology, Institute of Gastroenterology of Guangdong Province, Guangzhou, China
Citation: Lin S, Liu Q, Wen J, Bai K, Guo Y and Wang J (2020) Mir-124 Attenuates STAT3-Mediated TH17 Differentiation in Colitis-Driven Colon Cancer. Front. Oncol. 10:570128. doi: 10.3389/fonc.2020.570128
Received: 06 June 2020; Accepted: 09 November 2020;
Published: 17 December 2020; Retracted: 17 October 2024.
Edited by:
Lidia Karabon, Polish Academy of Sciences, PolandReviewed by:
Ying Ma, University of Texas MD Anderson Cancer Center, United StatesJi-Liang Li, University of Plymouth, United Kingdom